Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): Report from a single VEDOSS/EUSTAR centre

Annals of the Rheumatic Diseases

Volumn 74, Issue 1, 2015, Pages 124-128

  Lepri, Gemma ^a   Guiducci, Serena ^a   Bellando Randone, Silvia ^a   Giani, Iacopo ^b   Bruni, Cosimo ^a   Blagojevic, Jelena ^a   Carnesecchi, Giulia ^a   Radicati, Alessandra ^a   Pucciani, Filippo ^a   Marco, Matucci Cerinic ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b USL 8   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; CENTROMERE ANTIBODY;

ADULT; ANORECTAL DISEASE; ANORECTAL PRESSURE; ANTIBODY DETECTION; ANUS; ARTICLE; CAPILLAROSCOPY; CATHETER; CLINICAL FEATURE; COMPUTER PROGRAM; CONTROLLED STUDY; DEMOGRAPHY; ESOPHAGUS; ESOPHAGUS DISEASE; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; QUALITY OF LIFE; RAYNAUD PHENOMENON; RECTUM; SYSTEMIC SCLEROSIS; VERY EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS; ANAL CANAL; ANGIOSCOPY; ANUS DISEASES; COMPLICATION; EARLY DIAGNOSIS; ESOPHAGEAL DISEASES; LUNG; LUNG DISEASES; MANOMETRY; PATHOPHYSIOLOGY; RADIOGRAPHY; RAYNAUD DISEASE; RECTAL DISEASES; SCLERODERMA, SYSTEMIC;

ADULT; ANAL CANAL; ANUS DISEASES; EARLY DIAGNOSIS; ESOPHAGEAL DISEASES; ESOPHAGEAL SPHINCTER, LOWER; FEMALE; HUMANS; LUNG; LUNG DISEASES; MALE; MANOMETRY; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; RAYNAUD DISEASE; RECTAL DISEASES; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC;

EID: 84918783080     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203889     Document Type: Article

References (22)

1. Savarino E, Mei F, Parodi A, et al. Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology 2013;52:1095-100.
2. Marie I, Ducrotte P, Denis P, et al. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 2006;24:1593-601.
3. Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 2012;14:22-9.
4. Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci 2008;53:1163-74.
5. Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006;23:691-712.
6. Carette S, Lacourciere Y, Lavoie S, et al. Radionuclideesophageal transit in progressive systemic sclerosis. J Rheumat 1985;12:478-81.
7. Clements PJ, Becvar R, Drosos AA, et al. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003;21(3. Suppl. 29):515-18.
8. Ebert EC. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol 2008;42:5-12.
9. Herrick AL, Barlow JD, Bowden A, et al. Investigation of ananl function in patients with systemic sclerosis. Ann Rheum Dis 1996;55:370-74.
10. Kim KC, Park HJ, Lee SH, et al. Anorectal dysfunction in systemic sclerosis. J Korean Med Sci 1996;11:244-49.
11. Massone C, Milione L, Parodi A, et al. Anorectal involvement is frequent in limited systemic sclerosis. Acta Derm Venereol 2002;82:446-48.
12. Bellando Randone S, Guiducci S, Matucci Cerinic M. Patients subgroups and potential risk factors in systemic sclerosis: is there a possibility of an early diagnosis? Int J Clin Rheumatol 2010;5:555-64.
13. Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011;70:476-81.
14. Conchillo JM, Smout AJ. Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux. Aliment Pharmacol Ther 2009;29:3-14.
15. Cutolo M, Pizzorni C, Meroni M, et al. The role of nailfold videocapillaroscopy in Raynaud's phenomenon monitoring and early diagnosis of systemic sclerosis. Reumatismo 2010;62:237-47.
16. Arndorfer RC, Stef JJ, Dodds WJ, et al. Improved infusion system for intraluminal esophageal manometry. Gastroenterology 1977;73:23-7.
17. Murray JA, Clouse RE, Conklin JL. Components of the standard oesophageal manometry. Neurogastroenterol Motil 2003;15:591-606.
18. Rao SSC, Azpiroz F, Diamant N, et al. Minimum standards of anorectal manometry. Neurogastroenterol Mot 2002;14:553-59.
19. Valentini G, Cuomo G, Abignano G, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology 2011;50:317-23.
20. Matucci Cerinic M, Bellando Randone S, Lepri G, et al. Very early versus early disease: the evolving definition of the many faces of Systemic Sclerosis. Ann Rheum Dis 2013;72:319-22.
21. Rattan S. The internal anal sphincter: regulation of smooth muscle tone and relaxation. Neurogastroenterol Motil 2005;15(Suppl. 1):50-9.
22. Ponge T, Bruley des Varannes S. Digestive involvement of scleroderma. Rev Prat 2002;52:1896-900.